NCT07245524

Brief Summary

This is a prospective observational study conducted at the trauma center of Città della Salute e della Scienza of Turin. The aim of the study is to compare two local regional anesthesia techniques in multimodal analgesia for spine fusion: Intrathecal Morphine (IM) and the Erector Spinae Plane Block (ESPB). The effectiveness of these techniques is to be understood in terms of improved intraoperative and postoperative pain management. Primary outcome: ● Assessment of postoperative pain upon awakening using the NRS score (T0). The secondary outcomes are aimed at investigating whether one technique is more effective than the other in terms of reducing postoperative opioid consumption and therefore improving pain control in the first 24 hours. Any side effects and complications related to the two techniques will also be analyzed. Patients are enrolled by signing an informed consent form before surgery. At the time of surgery, an anesthesiologist experienced in locoregional techniques performs one of the two techniques (only those who have been specially trained can perform ESPB). A shared multimodal analgesia protocol is followed intraoperatively. In the postoperative period, standard analgesic therapy is set up and in the first 24 hours parameters, pain (NRS), any rescue medications administered and side effects and complications are recorded.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 30, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 24, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 24, 2025

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

September 30, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 24, 2025

Completed
Last Updated

November 24, 2025

Status Verified

November 1, 2025

Enrollment Period

1.1 years

First QC Date

September 30, 2025

Last Update Submit

November 17, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • NRS score T0

    Postoperative pain upon awakening (T0), measured using the NRS (Numeric rating scale) score.

    T0: up to 20 minutes after surgery

Secondary Outcomes (6)

  • NRS at 2 hours, 4 hours, 6 hours, 12 hours, 24 hours

    2 hours, 4 hours, 6 hours, 12 hours, 24 hours post surgery

  • Opioid consumption

    Consumption of morphine at 2 hours, 4 hours, 6 hours, 12 hours, 24 hours after surgery

  • Intraoperatory opioid consumption

    during the surgery

  • Rescue therapy request

    During the first 24 hours post surgery

  • Sides effects

    First 24 hours after surgery

  • +1 more secondary outcomes

Study Arms (2)

IM: Intrathecal Morphine

Patients treated with IM in association to multimodal analgesia

ESPB: Erector Spinae Plane Block

Patients treated with ESPB in association to multimodal analgesia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with presenting surgical indication for thoracolumbar spinal fusion with posterior access. The patients enrolled are being treated at the CTO (Trauma and Orthopedic Center) hospital in Turin.

You may qualify if:

  • Age \>=18 years
  • Patients with surgical indication for thoracolumbar spinal fusion with posterior access.
  • ASA I, II, III

You may not qualify if:

  • Patient refusal
  • Emergency surgery
  • Chronic use (\>12 weeks) of opioids in the preoperative period
  • Drug addiction
  • Contraindication to drugs contained in the protocol
  • Contraindications to performing a subarachnoid puncture or fascial block

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro Traumatologico Ortopedico (CTO) - AOU Città della Salute e della Scienza University Hospital

Torino, To, 10126, Italy

Location

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 30, 2025

First Posted

November 24, 2025

Study Start

August 30, 2024

Primary Completion

September 24, 2025

Study Completion

September 24, 2025

Last Updated

November 24, 2025

Record last verified: 2025-11

Locations